StockNYSERMD
ResMed
$235.30
-4.00 (-1.67%)today
Valuation & earnings
- P/E ratio
- 21.43
- Forward P/E
- 17.79
- EPS (ttm)
- $10.98
- Forward EPS
- $13.23
- Price/book
- 5.56
- PEG ratio
- 1.26
- Dividend yield
- 1.12%
- Payout ratio
- 22.4%
Financials (ttm)
- Revenue (ttm)
- 5.7B
- Revenue growth
- 5.9%
- Profit margin
- 27.79%
- Return on equity
- 26.4%
- Total cash
- 1B
- Total debt
- 610.6M
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Dec 31, 2025 | 2.72 | 2.81 | +3.15% |
| Mar 31, 2026 | 2.8 | 2.86 | +2.15% |
| Jun 30, 2026 | 2.89 | 2.95 | +1.98% |
| Sep 30, 2026 | 2.67 | 2.91 | +8.86% |
Next earnings date: Jan 28, 2027
Analyst view
Consensus ratingBuy20 analysts
Strong buy 2Buy 7Hold 10Sell 1
12-month price targetsImplied upside: +12.34%
210
264.33
320
LowCurrent priceHigh
Dividends
- Dividend yield
- 1.12%
- Dividend (annual)
- $2.64
- Ex-dividend date
- Nov 12, 2026
Recent payments
Aug 20, 2026 · $0.66May 14, 2026 · $0.60Feb 12, 2026 · $0.60Nov 13, 2025 · $0.60Aug 14, 2025 · $0.60
Related products
How visible is ResMed in AI search?
We ask AI search engines about ResMed and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for ResMed yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.